Does MACITENTAN Cause Pulmonary fibrosis? 144 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 144 reports of Pulmonary fibrosis have been filed in association with MACITENTAN (OPSYNVI). This represents 0.3% of all adverse event reports for MACITENTAN.
144
Reports of Pulmonary fibrosis with MACITENTAN
0.3%
of all MACITENTAN reports
76
Deaths
79
Hospitalizations
How Dangerous Is Pulmonary fibrosis From MACITENTAN?
Of the 144 reports, 76 (52.8%) resulted in death, 79 (54.9%) required hospitalization, and 5 (3.5%) were considered life-threatening.
Is Pulmonary fibrosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MACITENTAN. However, 144 reports have been filed with the FAERS database.
What Other Side Effects Does MACITENTAN Cause?
Dyspnoea (8,315)
Death (5,864)
Headache (4,856)
Diarrhoea (3,669)
Pneumonia (3,531)
Nausea (3,463)
Hospitalisation (3,414)
Fatigue (3,172)
Fluid retention (2,861)
Dizziness (2,704)
What Other Drugs Cause Pulmonary fibrosis?
METHOTREXATE (2,912)
ADALIMUMAB (2,277)
RITUXIMAB (2,192)
ETANERCEPT (1,926)
TOCILIZUMAB (1,886)
ABATACEPT (1,828)
HYDROXYCHLOROQUINE (1,740)
LEFLUNOMIDE (1,731)
PREDNISONE (1,692)
INFLIXIMAB (1,595)
Which MACITENTAN Alternatives Have Lower Pulmonary fibrosis Risk?
MACITENTAN vs MACITENTAN\TADALAFIL
MACITENTAN vs MAGNESIUM
MACITENTAN vs MAGNESIUM ASPARTATE
MACITENTAN vs MAGNESIUM ASPARTATE\POTASSIUM ASPARTATE
MACITENTAN vs MAGNESIUM HYDROXIDE